Evidence map›Paper›PMID 39984836›Full record

ArticleBMC infectious diseases2025

Some zoonotic infectious diseases are prevalent among children under 15 years of age in Ardabil Province, northern Iran.

Mehdi Mohebali, Behnaz Akhoundi, Shabnam Asfaram, Zabih Zarei, Seyyedeh-Negar Modares-Sadrani, Nader Noori, Abbas Hosseinzadeh, Sohrab Iranpour, Soheila Molaei

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mehdi MohebaliResearch Center for Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran.
Behnaz AkhoundiDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Shabnam AsfaramZoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Zabih ZareiDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Seyyedeh-Negar Modares-SadraniDeputy of Health, Ardabil University of Medical Sciences, Ardabil, Iran.
Nader NooriDeputy of Health, Ardabil University of Medical Sciences, Ardabil, Iran.
Abbas HosseinzadehDeputy of Health, Ardabil University of Medical Sciences, Ardabil, Iran.
Sohrab IranpourDepartment of Community Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Soheila MolaeiZoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. smolaie83@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study sought to investigate the seroprevalence of visceral leishmaniasis (VL), toxocariasis, brucellosis, and salmonellosis, as well as their co-infection and potential cross-reaction, in children under 15 years referred to health centers in Ardabil province, Iran, from 2019 to 2021.

methodsThe current study examined 1,550 serum samples using direct agglutination test (DAT), Toxocara canis ELISA, Wright, and Widal tests to detect antibodies against Leishmania, Toxocara, Brucella, and Salmonella, respectively. We also compared the test results to determine the possibility of cross-reactivity or simultaneous seropositivity in the tested samples.

resultsIn general, anti-Leishmania antibodies were positive in 78 samples (5%) at titers of ≥ 1:800, while only 8 cases had titers of ≥ 1:3200, which was considered as positive result. Therefore, the seroprevalence of VL was estimated to be at 5.16 per 1,000 at-risk populations. Meshkin-Shahr city had the highest seroprevalence (7 cases, 87.5%), followed by Ardabil (1 case, 12.5%) (p = 0.03). The highest and lowest seropositivity rates were observed in children aged 1-5 (6 samples, 75%) and 5-15 (2 samples, 25%) years old, respectively (p = 0.02). Anti-Toxocara antibodies were positive in 249 samples, (16.1%, 95% CI: 13.2-18.8), which were primarily males. There was a significant difference in seropositivity to Toxocara infection by city (p = 0.04), and age (p = 0.00). The results of Wright test showed seropositivity of 7.5% (117 samples) with the highest rate in individuals aged ≥ 10 years, males, and urban areas. No significant differences existed between the seropositivity rate and age, sex, residency, or symptoms (p > 0.05). Widal test was positive in 6% (94 samples) of children, with most cases being females (p < 0.05), particularly in those aged ≥ 10 years. Of the 78 DAT-positive sera, only 2 samples with a low titer (1:800) tested positive for anti-Toxocara antibodies, while none of the high titer samples were positive. In addition, samples with a DAT titer of 1:800 were positive for anti-Brucella (1:40: 10.2%, 1:80: 2.5%) and Salmonella (1:40: 3.8%) antibodies. The titers were (1:40: 5.1%, 1:80: 1.3%) for Brucella and (1:40: 2.5%) for Salmonella at a 1:1600 DAT titer. Wright's test on Toxocara-positive sera showed that 1.2% and 0.4% of samples had titers of 1:40 and 1:80, respectively. Furthermore, 2%, 2.8%, and 0.8% of Toxocara-positive samples exhibited anti-Salmonella antibodies at titers of 1:40, 1:40, and 1:80 corresponding to OA and OD antigens, respectively. The Wright (OR:1.099; 95% CI:1.080-1.118) and Widal (OR: 1.078; 95% CI: 1.062-1.094) tests showed cross-reactivity at low titers and minimal co-infection at high titers. Of Widal-positive sera, 11.4% with a titer of 1:40, and 2.7% with a titer of 1:80 were positive for anti-Brucella antibodies (OR:1.078; 95% CI:1.056-1.085).

conclusionGiven the prevalence of bacterial and parasitic febrile infections among children in the region, and their symptomatic similarity to VL, it is crucial to recognize clinical manifestations, accurately diagnose co-infections, and account for cross-reactivity in serological tests.

Indexed as

BrucellosisLeishmaniasis, VisceralSalmonella InfectionsToxocariasisZoonosesAdolescentAnimalsAntibodies, BacterialChildChild, PreschoolCoinfectionFemaleHumansInfantIranMaleAntibodies, BacterialBrucellosisCo-infectionCross-reactionSalmonellosisToxocariasisVisceral leishmaniasis

Identifiers

PMID39984836
PMCPMC11844169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.